Today is
Wednesday June 03, 2026
(NEW YORK) -- An emergency rule from the Florida Department of Health went into effect on Sunday that could restrict tens of thousands of people from accessing HIV medication.
The state issued cuts to the AIDS Drug Assistance Program (ADAP), a federal-state partnership that provides free FDA-approved HIV medication for low-income, uninsured or underinsured people.
Under the emergency rule, eligibility for ADAP was lowered to include those at or below 130% of the federal poverty level, which equals about $20,345 per year for a one-person household, according to the Department of Health and Human Services.
Previous eligibility was at or below 400% of the poverty level, which equals about $62,600 per year for a one-person household, according to HHS.
Additionally, the emergency rule limits insurance coverage of Biktarvy, a once-daily pill to treat HIV and used by about 60% of those enrolled in ADAP.
HIV advocates estimate that as many as 16,000 of the 30,000 Floridians enrolled in ADAP could be at risk of restricted access.
"These cuts will impact communities throughout the state, will threaten the lives of people with HIV and will lead to spikes in new HIV diagnoses and a rise in health care costs as people with HIV develop serious infections requiring hospitalization," said Dr. Anna K. Person, chair of the HIV Medicine Association, a community of health care professionals that works toward advancing the response of the HIV epidemic, in a statement.
"HIV treatment disruptions of this magnitude will result in a public health disaster. Florida must follow due process and work with health care professionals, people with HIV and the state legislature to address any funding challenges," the statement continued.
The new emergency rule is only in effect for 90 days and cannot be renewed unless a rule is proposed to implement the changes through formal administrative rulemaking.
Health officials have cited the "rising health care insurance premiums nationwide" and lack of federal funding as reason for the cuts. Officials said the adjustments will prevent a shortfall of more than $120 million for the state.
The Florida Department of Health did not immediately return ABC News' request for comment.
Copyright © 2026, ABC Audio. All rights reserved.
(NEW YORK) -- Measles cases have topped 1,000 in the United States for the third time in 26 years.
At least 154 new measles cases have been confirmed in the last week for a total of 1,136, according to updated data from the Centers for Disease Control and Prevention (CDC).
So far this year, cases have been confirmed in 27 states: Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kentucky, Maine, Minnesota, Nebraska, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Washington and Wisconsin.
Just six measles cases were reported among international travelers so far this year, according to CDC data.
About 92% of cases are among people who are unvaccinated or whose vaccination status is unknown, CDC data shows.
Meanwhile, 4% of cases are among those who have received just one dose of the measles, mumps, rubella (MMR) vaccine and 4% of cases are among those who received the recommended two doses, according to the CDC.
The current measles situation in the U.S. is partly being driven by a large outbreak in South Carolina that began last year, with 979 cases recorded as of Friday, according to state health officials.
Last year, the U.S. recorded 2,281 measles cases, which is the highest number of national cases in 33 years, according to the CDC. Before that, the last time measles cases rose above 1,000 was 2019 -- CDC data showed 1,274 that year. Recorded cases dropped to a low of 13 in 2020, the first year of the COVID-19 pandemic.
It also marked the first U.S. deaths recorded from measles in a decade, two among school-aged unvaccinated children in Texas and a third of an unvaccinated adult in New Mexico.
The CDC currently recommends people receive two doses of the MMR vaccine, the first at ages 12 to 15 months and the second between 4 and 6 years old. One dose is 93% effective, and two doses are 97% effective against measles, according to the CDC.
However, federal data shows vaccination rates have been lagging in recent years. During the 2024-2025 school year, 92.5% of kindergartners received the MMR vaccine, according to data. This is lower than the 92.7% seen in the previous school year and the 95.2% seen in the 2019-2020 school year, before the COVID-19 pandemic.
Copyright © 2026, ABC Audio. All rights reserved.
(NEW YORK) -- The number of women with risk factors for cardiovascular disease could significantly increase over the next 25 years, the American Heart Association (AHA) warned on Wednesday.
Without improving prevention and early detection tools, about six in 10 women could be diagnosed with hypertension or obesity by 2050, and risk factors could appear in children and teenagers as well, according to the AHA's scientific statement.
"Cardiovascular disease is the leading cause of death, and fewer than half of women know that fact," Dr. Stacey Rosen, executive director of Katz Institute for Women's Health and volunteer president of the AHA, told ABC News. "And the percentage of awareness is even lower in African Americans and Hispanics."
Published in the journal Circulation, the AHA's projections suggest that 59.1% of women could have high blood pressure by 2050 -- up from 48.6% in 2020 -- even as diet, physical activity and smoking rates are projected to improve.
About one in four women may have diabetes in 2050, up from 14.9% in 2020, and more than 60% are estimated to have obesity, an increase from 43.9% over the same period, according to the report.
Heart health risk factors won't hit all demographic groups of women equally, the report predicted.
High blood pressure will increase the most among Hispanic women with a projected rise of 15%, the report noted.
Additionally, more than 70% of Black women could have high blood pressure and obesity may increase the most among Asian women by nearly 26%.
Young women and girls may also see an increase in heart risk factors, partially driven by less opportunity for exercise as well as an abundance of inexpensive foods that often are not heart health.
Estimates also suggest that nearly one-third of girls between ages 2 and 19 will have obesity, an increase from 19.6% with obesity in 2020.
Dr. Jennifer Miao, a board-certified cardiologist, told ABC News that earlier hormonal changes in girls may also contribute to cardiovascular risk later in life.
"Several studies have also shown that starting menstruation at an early age can lead to increased risk of heart disease down the road," she said.
Miao said she counsels parents that it's never too early to start thinking of heart health for their children by "choosing good foods, physical activity over screen time and regular pediatrician check-ups."
Despite the report's predictions, Rosen stressed that meaningful progress for women's heart health is still within reach.
"As a medical community, we have amazing tools to treat disease and detect it early, but lack when it comes to primary prevention," Rosen said, adding that managing diseases like obesity requires a time intensive, multidisciplinary approach that the current U.S. health care system is not built to support.
She also said that optimizing health doesn't require a costly gym membership or expensive organic foods.
"Every bit of movement counts, whether that means taking a walk or standing more if you work at a desk," Rosen said.
Small, sustainable changes, like cutting back on sweetened beverages, can make a meaningful difference over time, she said.
Miao added that both the medical community and local leaders can do their part. By partnering with local health clinics, expanding home visit programs and leveraging telemedicine, health systems can extend their reach and bring essential care directly to isolated and underserved populations.
Takisha Morancy, MD, is a chief emergency medicine resident, medical ethics fellow and member of the ABC News Medical Unit.
Copyright © 2026, ABC Audio. All rights reserved.
(WASHINGTON) -- President Donald Trump's surgeon general nominee, Dr. Casey Means, indicated she supports vaccines but stopped short of recommending certain shots during her confirmation hearing before the Senate Health, Education, Labor and Pensions (HELP) committee on Wednesday.
Means, who has a medical degree but does not hold an active medical license, appeared hesitant to say that some vaccines, such as the flu vaccine, prevent serious disease.
When asked by HELP committee chair Sen. Bill Cassidy, R-La., if she would encourage mothers to vaccinate their children with the measles, mumps and rubella (MMR) vaccine amid widespread illness in the U.S., Means said, "I absolutely am supportive of the measles vaccine, and I do believe vaccines save lives and are important part of the public health strategy."
However, she stressed personal autonomy and said each patient or parent needs to have a conversation with their doctor or pediatrician before taking any medication.
Later in the hearing, Sen. Tim Kaine, D-Va., asked Means for her opinion on the efficacy of the flu vaccine.
"Do you believe that there is evidence that the flu vaccine prevents serious disease and prevents hospitalization or deaths in children?" Kaine said.
"I believe that all patients should talk to their doctor--" Means began answering.
"And so do I, and that's not what I'm asking," Kaine interjected.
"I support the CDC's guidance on the flu vaccine," Means replied, adding that she believes the shot reduced the risk of hospitalization "at the population level."
Earlier this year, the Centers for Disease Control and Prevention announced that it was changing the childhood immunization schedule, removing the universal recommendation for multiple shots, including the flu vaccine.
Means was originally scheduled to testify before the HELP committee in October, but her appearance was postponed for four months after she went into labor.
If confirmed, Means would become the nation's top doctor, leading more than 6,000 members of the U.S. Public Health Service, including physicians, nurses, scientists and engineers working at various federal health agencies.
Means' views largely mirror those of Health and Human Services Secretary Robert F. Kennedy Jr., with a focus on tackling the chronic disease epidemic, creating a healthier food supply and expressing vaccine skepticism.
This is a developing story. Check back for updates.
ABC News' Youri Benadjaoud and Arthur Jones II contributed to this report.
Copyright © 2026, ABC Audio. All rights reserved.
(NEW YORK) -- U.S. childhood and teen obesity rates have reached record-highs while adult obesity rates may be slowing, according to two new reports published early Wednesday by the Centers for Disease Control and Prevention (CDC).
Researchers used measured heights and weights from the National Health and Nutrition Examination Survey (NHANES) -- run by the CDC's National Center for Health Statistics -- to track trends over more than six decades.
In the first report, the team found that, in the most recent survey conducted between August 2021 and August 2023, 40.3% of adults aged 20 and older were found to be obese, including 9.7% with severe obesity and another 31.7% classified as overweight.
By comparison, for the survey conducted between 1988 and 1994, 22.9% adults aged 20 and older were found to be obese including 2.8% with severe obesity and 33.1% classified as overweight.
However, some of the newest estimates suggest the rapid rise seen in earlier decades may be slowing slightly.
In the 2017-2018 survey, 42.4% of adults were classified as obese, which is the highest figure ever recorded. The decrease between the two most recent surveys could be indicative of a downward trend. Dr. John Brownstein, an epidemiologist and chief innovation officer at Boston Children's Hospital and an ABC News contributor, noted that it aligns with observations of electronic medical record data.
"So, we're seeing, for the first time in decades, that there's like a leveling off and even maybe a slight decrease and I think this is like challenging a major shift from the long-held expectation that obesity would just be climbing year after year," he said.
According to Brownstein, the decrease is likely due to many factors including public health policies and education about healthier lifestyles as well as medications such as GLP-1s.
GLP-1s, or glucagon-like peptide-1 receptor agonists, mimic the GLP-1 hormone that is produced in the gut after eating.
It can help produce more insulin, which reduces blood sugar and therefore helps control Type 2 diabetes. It can also interact with the brain and signal a person to feel full, which -- when coupled with diet and exercise -- can help reduce weight in those who are overweight or obese.
Many GLP-1s have become household names, including Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity.
"I do think the advent of the GLP-1s are absolutely playing a role," Brownstein said. "At that point in 2023, they weren't as widespread as they are today. So, we expect that these factors could play even more significant role in more recent times."
Dr. Justin Ryder, an associate professor of surgery and pediatrics at Northwestern Feinberg School of Medicine, said he's cautiously optimistic about the slight decrease.
However, he added that it remains to be seen whether this is a blip or if the decrease is indicative of a longer-term trend.
"We've seen dips in the past and typically, when they do, in the next reporting period it goes right back up," Ryder told ABC News. "And that's because of how the sampling is done. This is a random sample of U.S. adults."
He noted that the random sampling makes it difficult to draw firm conclusions.
"Could it just be the people who were sampled, or is it real?" he said. "And I think we won't know that until we have another set or a larger set of data over either the same sampling period or a couple more years from now."
Meanwhile, a second report found that more than one in five U.S. children and teenagers have obesity, which is the highest figure ever recorded.
The survey conducted between August 2021 and August 2023 found 21.1% of U.S. children and teenagers between ages 2 and 19 have obesity, up from 5.2% during the 1971-1974 survey.
Additionally, 7% of children live with severe obesity, an increase from the 1% seen 50 years ago, according to the report.
"This is exceptionally concerning," Dr. David Ludwig, co-director of the New Balance Foundation Obesity Prevention Center at Boston Children's Hospital and professor of nutrition at Harvard School of Public Health, told ABC News.
He added that in the 1970s, "children were certainly recognized [as obese] but it was the rare child, one in 20. And now we're looking at one in five children with obesity."
Ludwig said it had seemed for a short period of time that the prevalence of obesity was decreasing at least among 2-to-5-year-olds when rates declined from 12.1% in 2009-2010 to 9.4% in 2013-2014.
At the time, he viewed it as a "glimmer of hope" -- but rates increased again and now sit at 14.9% for this age group.
"We saw that dip and we all got excited thinking that we were beginning to turn the tide," Ludwig said. "In retrospect, that was more of a statistical aberration, more of mirage than a true glimmer of hope because the trend overall has continued upward."
To reverse the trends among children, Ryder said the 2-to-5-year-old group will need lifestyle modifications such as healthier eating. The 6-to-11-year-old group will need similar methods although some medications are available, he said.
For children above age 12, Ryder said medications and bariatric surgery are options.
Nearly 23% of children ages 12 to 19 were considered obese in the most recent survey. Ryder said that means they meet the guidelines for intensive treatment, whether that's lifestyle adjustments or in combination with medications or surgery.
"I think the only way that we're going to see a downward trend in that number is if we take that adolescent group of 12- to 19-year-olds and actually start to apply the clinical practice guidelines and treat those kids seriously, offering them medications," he said.
Ishani D. Premaratne, MD, is an integrated plastic & reconstructive surgery resident and member of the ABC News Medical Unit.
Copyright © 2026, ABC Audio. All rights reserved.
(NEW YORK) -- The U.S. is close to reaching at least 1,000 measles cases for the third time in eight years.
At least 72 new measles cases have been confirmed in the last week, according to updated data from the Centers for Disease Control and Prevention.
So far this year, there have been total of 982 cases in 26 states, including Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kentucky, Maine, Minnesota, Nebraska, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Washington and Wisconsin.
Just six measles cases were reported among international travelers so far this year, according to CDC data.
About 94% of cases are among people who are unvaccinated or whose vaccination status is unknown, the CDC said.
Meanwhile, 3% of cases are among those who have received just one dose of the measles, mumps, rubella (MMR) vaccine and 4% of cases are among those who received the recommended two doses, according to the CDC.
The current measles situation in the U.S. is partly being driven by a large outbreak in South Carolina that began last year, with 962 cases recorded as of Friday, according to state health officials.
Last year, the U.S. recorded 2,281 measles cases, which is the highest number of national cases in 33 years, according to the CDC.
It also marked the first U.S. deaths recorded from measles in a decade, two among school-aged unvaccinated children in Texas and a third among an unvaccinated adult in New Mexico.
The CDC currently recommends people receive two doses of the MMR vaccine, the first at ages 12 to 15 months and the second between 4 and 6 years old. One dose is 93% effective, and two doses are 97% effective against measles, the CDC said.
However, federal data shows vaccination rates have been lagging in recent years. During the 2024-2025 school year, 92.5% of kindergartners received the MMR vaccine, according to data. This is lower than the 92.7% seen in the previous school year and the 95.2% seen in the 2019-2020 school year, before the COVID-19 pandemic.
Last month marked one year since a measles outbreak began in West Texas, with infections soon spreading to neighboring counties and other states.
Public health experts previously told ABC News that if cases in other states are found to be linked to the cases in Texas, it would mean the virus has been spreading for a year, which could lead to a loss of elimination status.
Copyright © 2026, ABC Audio. All rights reserved.